INHSU has collaborated with the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) and the Kirby Institute at the University of New South Wales (UNSW Sydney) to develop and deliver hepatitis C education, globally.
Our program is delivered in three parts:
Hepatitis C online learning modulesCountry-specific, online learning modules related to epidemiology, natural history, assessment, management and treatment of hepatitis C for people who use drugs.
Our workshopsOur interactive workshops enable the practical and collaborative application of concepts and theory through case discussions, facilitated by experts in the field of hepatitis C.
Tailored toolkitsCapacity strengthening toolkit providing participants with practical tools with which to implement hepatitis C testing and treating processes in their setting.
Where is it taking place?
INHSU, in collaboration with ASHM, the Kirby Institute, and local partners, offers tailored, country-specific hepatitis C education for healthcare practitioners.
Why is it important?
Globally, HCV-related morbidity and mortality are rising due to large populations with chronic infection, an ageing infected population and low treatment uptake.
However, following the advent of well-tolerated, simple, short-course direct acting antiviral (DAA) interferon-free HCV treatment regimens with cure rates >95%, there is potential to reverse the rising burden of disease with increased treatment. By expanding HCV care into primary care and drug and alcohol settings we have an opportunity to enhance HCV assessment, management and treatment, particularly among people who use drugs.
Who should take part?
The Program is designed for healthcare practitioners working in primary care or drug and alcohol settings or working with people who use drugs.
The Program is tailored for each country in close collaboration with local stakeholders to ensure education materials and resources are in-line with local guidelines and appropriately support increased HCV screening, linkage-to-care and treatment for people living with HCV.
If you are interested in access the Education Program but do not see your country listed, please contact email@example.com
Our free workshops are designed for healthcare providers, giving you an opportunity to put your learnings from the online learning modules into practice, network with other like-minded professionals and build local links and referral pathways. Click the button below to see a list of all upcoming workshops.
- Germany, national, 28 September 2022
- England, National, 04 October 2022
- Germany, 15 November 2022
International steering committee
The education program is developed and delivered in collaboration with many partners. The International Education Program Steering Committee provide oversight and direction to the Program and we thank them for their involvement.
Prof. Jason Grebely | Senior Research Fellow/President | Viral Hepatitis Clinical Research Program, The Kirby Institute/INHSU | Australia
Ms. Emma Day | Executive Director | International Network on Health and Hepatitis in Substance Users | Australia
Dr. Alessio Aghemo | Professor of Gastroenterology | Humanitas University | Italy
Prof. John Dillon | Professor of Hepatology and Gastroenterology | Ninewells Hospital, University of Dundee | UK
Dr. Martin Kåberg | Addiction/Infectious Disease | The Stockholm Centre for Dependency | Sweden
Prof. Karine Lacombe | Professor | Infectious and Tropical Diseases Department, Saint-Antoine Hospital | France
Ms. Nikitah Habraken | Program Manager | International Network on Health and Hepatitis in Substance Users | Australia
Prof. Jeffrey V. Lazarus | Associate Professor/Associate Researcher | University of Barcelona/ISGlobal, Hospital Clinic, University of Barcelona | Spain
Prof. Rui Tato Marinho | Gastroenterology Physician | Hospital Santa Maria | Portugal
Dr Alberto Moriggia | MD, Infectious Disease Specialist | Epatocentro Liver Clinic and Ingrado Addiction Clinic | Switzerland
Dr. Anne Øvrehus | Staff Specialist, Infectious Diseases | Department of Infectious Diseases, Odense University Hospital | Denmark
Prof. Jens Reimer | Professor of Psychiatry | University Medical Center Hamburg | Germany
Dr. Hemant Shah | Hepatologist & Education Director | University Health Network & Toronto Centre for Liver Disease | Canada
Prof. Marta Torrens | Addiction Specialist | Hospital del Mar, Barcelona | Spain